Background: We sought to assess the effect of non-traumatic intracranial hemorrhages on post-vaccinated (Moderna) participants. Methods: The researchers queried the Trinetx (Covid 19 Research Network) database of 63 health care organizations. They analyzed data from January 20th 2020 - July 30th 2021 and identified (n=612,450) Moderna vaccination cases between the ages of 18-90. The researchers identified (n=100) cases with non-traumatic intracranial hemorrhage and defined them with the use of ICD 10 code I62 and associated sub codes. We compared all-cause mortality, stroke, critical care, and cases of myocardial infarction between propensity matched (PSM) pairs of patients. Results: A total of (n=612,450) Moderna cases were included. Within the Moderna group, 100 (0.001%) had a non-traumatic intracranial hemorrhage. Those with a confirmed hemorrhage were older (74.3±11.8 vs 54.8± 19.2, P<0.01) and had higher key co-morbidities. A total of (n=74,655) (Table 1). Conclusions: In a large multi-national database of patients with SARS-CoV-2 Vaccine, we identified several cases of non-traumatic internarial hemorrhage. [Formula presented]
Effect of Non-Traumatic Intracranial Hemorrhages on Post-Vaccinated (Moderna) Participants